Biochimica Et Biophysica Acta-molecular Basis Of Disease

Journal Title：Biochimica Et Biophysica Acta-molecular Basis Of Disease

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease. This journal covers aspects of aging, cancer, metabolic-, neurological-, and immunological-based disease. Manuscripts focused on using animal models to elucidate biochemical and mechanistic insight in each of these conditions, are particularly encouraged. Manuscripts should emphasize the underlying mechanisms of disease pathways and provide novel contributions to the understanding and/or treatment of these disorders. Highly descriptive and method development submissions may be declined without full review. The submission of uninvited reviews to BBA - Molecular Basis of Disease is strongly discouraged, and any such uninvited review should be accompanied by a coverletter outlining the compelling reasons why the review should be considered.

BBA 疾病的分子基础 (BBA Molecular Basis of Disease) 致力于解决疾病过程和人类疾病模型的生物化学和分子遗传学问题。该期刊涵盖衰老、癌症、代谢、神经和免疫疾病等方面的内容。特别鼓励投稿专注于使用动物模型阐明每种疾病的生化和机制见解。稿件应强调疾病途径的潜在机制，并为理解和/或治疗这些疾病提供新颖的贡献。高度描述性和方法开发性投稿可能会在未经全面审查的情况下被拒绝。强烈反对向 BBA - 疾病的分子基础 (BBA - Molecular Basis of Disease) 提交未经邀请的评论，任何此类未经邀请的评论都应附上一封求职信，概述应考虑该评论的令人信服的理由。

Biochimica Et Biophysica Acta-molecular Basis Of Disease创刊于1947年，由Elsevier出版商出版，收稿方向涵盖生物 - 生化与分子生物学全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 一般,3-6周 约8.8周，影响因子指数4.2，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。